Investments
33Portfolio Exits
10Funds
2Service Providers
1About Integra Ventures
Integra Ventures is a Seattle, Washington-based investment firm making private equity and venture capital investments across stages from seed to growth equity to recaps. Integra is primarily focused on healthcare companies based on the west coast of the United States with an emphasis on the Pacific Northwest (Oregon and Washington). Integra's investment size typically ranges from $500,000 to $2 million, and the firm generally prefers to co-invest with an investment syndicate. The firm generally aims to take a Board seat or Board observer role.

Want to inform investors similar to Integra Ventures about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Integra Ventures
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Integra Ventures in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Latest Integra Ventures News
Jan 14, 2013
Apple Joseph Piper from Integra Ventures is a member of FundingPost online! Venture Fund Member Profile Share This Profile: We seek investments in seed to later-stage Life Science companies. We consider business plans from experienced entrepreneurs passionately pursuing outsourcing products/services related to healthcare software applications, bio-informatics, biotechnology tools, medical devices, and the Internet. Though we seek opportunities across America, we focus on locating innovative companies in the West, and invest predominantly in companies requiring less than $5 million of initial capital. Our investments range in size from $500,000 to $3 million. We usually position our investments as a part of a syndicate, partnering with firms that also have technical or market expertise, capital depth, and/or strategic influence. We have led deals in early-stage companies as well as followed other funds in later-stage developments. Joseph Piper Managing Partner Integra Ventures Joseph Piper directs the overall investment strategy for Integra Ventures. Since 1983, he has been involved with corporate governance, formation, growth, senior management, mergers and acquisitions, and investment in the healthcare industry. He currently sits on the board of four Integra Ventures portfolio companies: National Healing, HealthHelp, Physicians Edge, and Cara Vita. Joseph also serves as an advisor to the Long Term Care Foundation, a non-profit foundation dedicated to improving the quality of life for seniors.Prior to founding Integra Ventures, Joseph co-founded and served as President of Capital Services for Diversified Health Services (DHS), the largest post-acute care outsourcing management firm in the U.S. at the time, which was later sold to ServiceMaster (NYSE: SVM).Before moving to DHS, Joseph was Chief Corporate Counsel and Chief Operating Officer for the Voluntary Hospitals of America Long Term Care Group. His duties included integrating a post-acute strategy into hospital delivery systems through acquisitions, leasing, development, financing and management of sub-acute facilities with hospitals.Early in his career, Joseph served as Corporate Counsel for The Hillhaven Corporation, the nation's second largest extended care company. As one of two staff attorneys, his responsibilities included acquiring, leasing, developing and financing 350 facilities over a 2 1/2-year period - a total capitalization of approximately $980 million.Joseph holds an M.B.A. from the University of Colorado, as well as a Juris Doctor Degree from Seattle University. He earned his B.S. in Business from Arizona State University where he also played basketball. Representative Investments Blue Heron Blue Heron is a biotechnology tools company, which has developed proprietary technology to rapidly synthesize custom-engineered genes. One of the major bottlenecks in genetic research for pharmaceutical and agricultural companies is the time and effort required to prepare genes for detailed analysis. Blue Heron's outsourced service enables researchers to go directly from planning molecules on the desktop, ordering them over the web, to testing them in the lab. Blue Heron targets difficult to clone genes and variants that biotech companies are unable to produce themselves. Calypso Medical Technologies, Inc. Calypso Medical Technologies, Inc., is an early-stage medical device company founded in 1999. In the next few years, cancer will exceed heart disease as the leading cause of death in the US. We believe there are significant unmet needs in the treatment of cancer. The company is developing innovative tools and therapies for the oncology market that address these unmet needs. Calypso has assembled an experienced management team, world-class biomedical engineers and scientists, and an extensive scientific advisory board that rivals established medical technology organizations. Cara Vita Cara Vita has developed a cost-effective health maintenance approach to caring for the chronically frail elderly in non-skilled settings. While principally a residential care provider, Cara Vita has integrated private home health and day care programs into its facilities to provide an alternative for those seniors and their families who are not yet prepared for a residential program. Cara Vita is built on a care model designed to enhance resident health and allow high acuity residents to remain in Cara Vita's facilities longer, and age in place gracefully. National Healing National Healing is a disease management company with a focused expertise in managing wound treatment centers inside client hospitals. The Company has established 40 clinics with hospital clients including: Columbia, Quorum, MedCath, and several independent hospitals. In their centers, National Healing provides high-quality, cost-effective methodologies to expedite the healing of wounds and reduce inpatient stays. About FundingPost For over Fourteen Years FundingPost has worked with thousandsof Angel and Venture Capital Investors. We believe that it isimportant to reach investors in every medium possible -both online and offline. We have been directly responsible fortons of success stories and Millions and Millions of dollars raised.We look forward to introducing your company to the leading Venture and Angel Investors nationwide. Sign up now: Entrepreneurs / Investors Join the FundingPost email list and learn how, when and where you can meet these Investors: Other Venture Profiles:
Integra Ventures Investments
33 Investments
Integra Ventures has made 33 investments. Their latest investment was in Kerdea Technologies as part of their Unattributed VC on May 5, 2020.

Integra Ventures Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
5/5/2020 | Unattributed VC | Kerdea Technologies | $0.15M | Yes | 1 | |
8/2/2013 | Unattributed VC | MediQuest Therapeutics | $0.25M | No | 1 | |
2/28/2013 | Series B | Ampla Pharmaceuticals | $3.65M | No | 1 | |
10/5/2011 | Series D - II | |||||
5/18/2011 | Series B - III |
Date | 5/5/2020 | 8/2/2013 | 2/28/2013 | 10/5/2011 | 5/18/2011 |
---|---|---|---|---|---|
Round | Unattributed VC | Unattributed VC | Series B | Series D - II | Series B - III |
Company | Kerdea Technologies | MediQuest Therapeutics | Ampla Pharmaceuticals | ||
Amount | $0.15M | $0.25M | $3.65M | ||
New? | Yes | No | No | ||
Co-Investors | |||||
Sources | 1 | 1 | 1 |
Integra Ventures Portfolio Exits
10 Portfolio Exits
Integra Ventures has 10 portfolio exits. Their latest portfolio exit was Tepha on July 27, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
7/27/2021 | Acquired | 3 | |||
3/15/2017 | Acquired | 3 | |||
12/22/2016 | Reverse Merger | 3 | |||
Date | 7/27/2021 | 3/15/2017 | 12/22/2016 | ||
---|---|---|---|---|---|
Exit | Acquired | Acquired | Reverse Merger | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 3 | 3 | 3 |
Integra Ventures Fund History
2 Fund Histories
Integra Ventures has 2 funds, including IV-III LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
10/1/2002 | IV-III LP | Early-Stage Venture Capital | Closed | $33M | 1 |
12/31/1998 | IBH II LP |
Closing Date | 10/1/2002 | 12/31/1998 |
---|---|---|
Fund | IV-III LP | IBH II LP |
Fund Type | Early-Stage Venture Capital | |
Status | Closed | |
Amount | $33M | |
Sources | 1 |
Integra Ventures Service Providers
1 Service Provider
Integra Ventures has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
Counsel | General Counsel |
Service Provider | |
---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type | General Counsel |
Partnership data by VentureSource
Integra Ventures Team
1 Team Member
Integra Ventures has 1 team member, including current Founder, Managing Director, Joseph Piper.
Name | Work History | Title | Status |
---|---|---|---|
Joseph Piper | Founder, Managing Director | Current |
Name | Joseph Piper |
---|---|
Work History | |
Title | Founder, Managing Director |
Status | Current |